Houston Lung Symposium, April 28-29, 2012

http://houstonpathologists.org/upcomingevents.html


Houston Lung Symposium, April 28-29, 2012
2012 Spring Symposium!
Combining the Houston Society of Clinical Pathologists (HSCP) Spring Seminar and The Methodist Hospital Department of Pathology and Laboratory Medicine Advances in Lung Cancer Seminar
Location: The Methodist Hospital Research Institute, Texas Medical Center
Houston, Texas
Conference Hotel: Houston Marriott Hotel at the Texas Medical Center

Saturday, April 28, 2012
HSCP: Diagnostic Pulmonary Pathology

"Benign Tumors and Tumor-Like Conditions of the Lung"
Alain Borczuk, M.D.
Department of Pathology and Cell Biology
Columbia University Medical Center

"Update on Mesothelioma"
Lucian Chirieac, M.D.
Brigham and Women's Hospital
Harvard Medical School

"Separation of Benign v. Malignant Mesothelial Proliferations"
Andrew Churg, M.D.
Chair, United States-Canadian Mesothelioma Reference Panel
University of British Columbia, Canada

"Update on Idiopathic Interstitial Pneumonias"
Thomas Colby, M.D.
Chair, Department of Laboratory Medicine and Pathology
Mayo Clinic Arizona

"Dilemmas in Lung Cancer Staging"
Sanja Dacic, M.D. Ph.D.
University of Pittsburgh Medical Center
Deputy Editor in Chief, Archives of Pathology and Laboratory Medicine

"Pulmonary Pathology of the Rheumatic Diseases"
Kevin Leslie, M.D. Department of Laboratory Medicine and Pathology
Mayo Clinic, Arizona

"Proposed New Classification of Lung Cancer"
Keith Kerr, M.D.
Aberdeen Royal Infirmary
Aberdeen University Medical School
Scotland, UK

"The Changing Role of Pathology in Managing Patients with Unexplained Diffuse Lung Disease"
Jeffrey Myers, M.D.
Director of Anatomic Pathology
University of Michigan

Sunday, April 29, 2012
The Methodist Hospital Department of Pathology and Laboratory Medicine: Advances in Lung Cancer Seminar

"Treatment of ALK-positive NSCLC"
Yung-Jue Bang, M.D., Ph.D.
Professor of Medical Oncology
Chairman, Department of Internal Medicine
Seoul National University College of Medicine
Director, Clinical Trials Center, Seoul National University Hospital
Seoul, Korea

"Worldwide Overview of the Current Status of Lung Cancer Diagnosis and Treatment"
Paul Bunn, M.D.
Executive Director, International Association for the Study of Lung Cancer
James Dudley Chair in Cancer Research
University of Colorado, Denver
Director of the University of Colorado, Comprehensive Cancer Center

"Volumetric Optical Frequency Domain Imaging of Lung Pathology: Improving Biopsy Sampling and Evaluation"
Lida Hariri, M.D., Ph.D.
Massachusetts General Hospital
Harvard Medical School

"Cryobiopsy in Pulmonary Diseases"
Jurgen Hetzel, M.D.
Department of Medicine, University of Tuebingen
Germany

"Strategies to Overcome Resistance to EGFR Target Therapies"
Pasi A. Janne, M.D. Ph.D. 
Lowe Center for Thoracic Oncology
Dana-Farber Cancer Institute
Harvard Medical School

"Screening for Lung Cancer: Who Should be Screened?"
James Jett, M.D.
Editor in Chief, Journal of Thoracic Oncology
Dana-Farber Cancer Institute
Harvard Medical School

"Clinical Genotyping of Lung Cancer: Beyong EGFR and EML4-ALK, Beyong Adenocarcinoma"
Marc Ladanyi, M.D.
The William Ruane Chair in Molecular Oncology, Attending Pathologist
Molecular Diagnotics Service Member
Human Oncology and Pathogenesis Program Memorial Sloan-Kettering Cancer Center
New York, New York

"EGFR, ALK and KRAS Molecular Testing in Lung Adenocarcinoma: Why, When and How"
Neal I. Lindeman, M.D.
Molecular Diagnostics at Brigham & Women's Hospital
Harvard Medical School

"Advancing Personalized Cancer Medicine in Lung Cancer"
Laura MacConaill, Ph.D.
Scientific Director for the Center for Cancer Genome Discovery
Personalized Cancer Medicine Partnership
Dana-Farbar Cancer Institute & Brigham and Women's Hospital, Senior Scientist
Harvard Medical School

"Molecular Pathology of Lung Cancer: Changes in Prevention and Therapy Paradigms"
Ignacio Wistuba, M.D.
Department of Pathology
MD Anderson Cancer Center

"Lung Cancer Differential Diagnosis by Label-free, Molecular Vibrational Imaging"
Steve Wong, Ph.D.
PE Chairman, Department of Systems Medicine and Bioengineering
Director, NCI Center for Modeling Cancer Development
John S. Dunn Distinguished Endowed Chair in Biomedical Engineering
Chief of Medical Physics and Chief Research Information Officer
The Methodist Hospital

"Role of Cytopatholgy in the Molecular Diagnostics and Targeted Therapy of Lung Cancer"
Maureen Zakowski, M.D.
Director, Cytopathology Fellowship Program, Memorial Sloan Kettering Cancer Center